-
目前,肥胖已成为影响国人健康的高发病之一,手术减重明显优于内科减重治疗。腹腔镜Roux-en-Y胃旁路手术成为最常见的减重手术,但其手术风险较高,且为不可逆型手术,手术相应的并发症亦有报道。目前手术指征虽形成初步共识,但仍存在较大争议。如何进一步选择适合的手术病例成为研究热点。脂肪量和肥胖相关(fat mass and obesity associated, FTO)基因的单核苷酸多态性(single-nucleotide polymorphism, SNP)与儿童和成年人的肥胖有很强的相关性。本研究通过检测肥胖病人的FTO基因rs9939609多态性,比较不同基因型病人接受减重手术后近远期疗效差异性,从而为减重手术提供参考依据,使得制定手术指征更加合理、科学。现作报道。
-
FTO rs9939609多态性位点共检出存在TT、TA、AA 3种基因型,分别为:TT 46例(76.67%),TA 13例(21.67%),AA 1例(1.67%)。A等位基因频率为0.123,T等位基因频率为0.877,符合Hardy-Weinberg平衡(P=0.960)。由于AA个体数量较少,与TA合并进行统计分析(AA+TA)。TA+AA组和TT组病人在性别、年龄、术前及术后各时间点BMI、FBG差异无统计学意义(P>0.05)。TA+AA组术前、术后3个月2hPG显著高于TT组(P < 0.05), 而术后6个月、12个月2hPG差异无统计学意义(P>0.05)(见表 1~2)。
分组 男 女 年龄(x±s)/岁 TA+AA组 10 4 22.46±17.50 TT组 37 9 23.59±14.97 t 0.51* 0.24 P >0.05 >0.05 *示χ2值 表 1 2组病人一般资料比较
分组 术前 术后3个月 术后6个月 术后12个月 BMI/(kg/m2) TA+AA组 37.87±6.23 30.63±6.26 28.46±5.28 28.01±5.19 TT组 36.45±7.25 30.12±6.58 29.13±5.19 28.09±4.93 t 0.66 0.26 0.42 0.05 P >0.05 >0.05 >0.05 >0.05 FBG/(mmol/L) TA±AA组 8.25±3.44 7.53±3.46 6.87±2.37 6.78±3.02 TT组 7.89±3.25 7.35±3.13 7.02±2.98 7.04±3.28 t 0.36 0.18 0.17 0.26 P >0.05 >0.05 >0.05 >0.05 2hPG/(mmol/L) TA±AA组 16.15±8.83 15.31±9.23 10.28±6.34 9.89±6.12 TT组 10.47±4.82 9.12±4.18 9.23±4.58 9.21±4.43 t 2.15 2.15 0.68 0.46 P < 0.05 < 0.05 >0.05 >0.05 表 2 2组手术前后BMI、FBG和2hPG比较(x±s)
FTO基因的单核苷酸多态性对腹腔镜Roux-en-Y胃旁路手术疗效的影响
Effect of single-nucleotide polymorphism of the FTO gene on laparoscopic Roux-en-Y gastric bypass
-
摘要:
目的研究FTO基因的单核苷酸多态性对肥胖病人腹腔镜Roux-en-Y胃旁路手术疗效的影响。 方法选取肥胖病人60例,实施腹腔镜Roux-en-Y胃旁路手术。记录术前、术后1、3、6、12个月的体质量指数(BMI),并测定血清空腹葡萄糖(FPG)、餐后2小时血糖(2hPG)。并检测病人FTO基因的单核苷酸多态性。 结果检出存在TT、TA、AA 3种种基因型,分别为TT 46例(76.67%),TA 13例(21.67%),AA 1例(1.67%)。由于AA个体数量较少,和TA合并进行统计分析(AA+TA组)。AA+TA组与TT组病人在性别、年龄、术前及术后各时间点BMI、FBG差异无统计学意义(P>0.05)。TA+AA组在术前、术后3个月2hPG显著高于TT组(P < 0.05),而术后6个月、12个月2hPG差异无统计学意义(P>0.05)。 结论对于rs9939609 A等位基因的病人存在潜在2型糖尿病的可能,无论血糖是否正常都应当实施腹腔镜Roux-en-Y胃旁路手术;而rs9939609 T等位基因的单纯肥胖病人可以实施袖状胃切除。 Abstract:ObjectiveTo explore the effects of single-nucleotide polymorphism of the FTO gene on laparoscopic Roux-en-Y gastric bypass. MethodsSixty fat patients were treated with the laparoscopic Roux-en-Y gastric bypass.The body mass index(BMI), serum fasting plasma glucose(FPG) and blood glucose at 2 hours after meal(2hPG) before operation, and after 1, 3, 6 and 12 months of operation were measured, and recorded, and the single-nucleotide polymorphism of FTO gene were detected in all cases. ResultsThe TT(46 cases, 76.67%), TA(13 cases, 21.67%) and AA(1 case, 1.67%) genotypes were identfied.Due to the small number of AA individuals, the AA group and TA group was put together for analyzing.The differences of the sex, age, BMI and FBG at preoperative and postoperative time points were not statistically significant between two groups(P>0.05).The 2hPG in TA+AA group before operation and postoperative 3 months were significantly higher than that in TT group(P < 0.05), while the differences of 2hPG between two groups after 6 and 12 months of operation were not statistically significant(P>0.05). ConclusionsThe potential type 2 diabetes patients may exists the rs9939609 A allele, the laparoscopic Roux-en-Y gastric bypass should be implemented regardless of whether their blood glucose is normal, and the sleeve gastrectomy in simple obesity patients with rs9939609 T allele may be performed. -
Key words:
- obesity /
- FTO gene /
- single-nucleotide polymorphism /
- laparoscopy
-
表 1 2组病人一般资料比较
分组 男 女 年龄(x±s)/岁 TA+AA组 10 4 22.46±17.50 TT组 37 9 23.59±14.97 t 0.51* 0.24 P >0.05 >0.05 *示χ2值 表 2 2组手术前后BMI、FBG和2hPG比较(x±s)
分组 术前 术后3个月 术后6个月 术后12个月 BMI/(kg/m2) TA+AA组 37.87±6.23 30.63±6.26 28.46±5.28 28.01±5.19 TT组 36.45±7.25 30.12±6.58 29.13±5.19 28.09±4.93 t 0.66 0.26 0.42 0.05 P >0.05 >0.05 >0.05 >0.05 FBG/(mmol/L) TA±AA组 8.25±3.44 7.53±3.46 6.87±2.37 6.78±3.02 TT组 7.89±3.25 7.35±3.13 7.02±2.98 7.04±3.28 t 0.36 0.18 0.17 0.26 P >0.05 >0.05 >0.05 >0.05 2hPG/(mmol/L) TA±AA组 16.15±8.83 15.31±9.23 10.28±6.34 9.89±6.12 TT组 10.47±4.82 9.12±4.18 9.23±4.58 9.21±4.43 t 2.15 2.15 0.68 0.46 P < 0.05 < 0.05 >0.05 >0.05 -
[1] 潘凯, 杨雪菲.腹腔镜胃肠外科手术学[M].2版.北京:人民卫生出版社, 2010. [2] HINNEY A, NGUYEN TT, SCHERAG A, et al.Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants[J].PLoS One, 2007, 2(12):e1361. [3] SCUTERI A, SANNA S, CHEN WM, et al.Genome wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits[J].PLoS Genet, 2007, 3(7):e115. [4] WEEDON K, SJOLIN E, HOFFSTEDT J, et al.The common rs9939609 gene FTO is related to fat cell lipolysis[J].J Lipid Res, 2008, 49(3):607. [5] HUNT SC, STONE S, XIN Y, et al.Association of FTO gene with BMI[J].Obesity (Silver Spring), 2008, 16(4):902. [6] ANDREASEN CH, STENDER-PETERSEN KL, MOGENSEN MS, et al.Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation[J].Diabetes, 2008, 57(1):95. [7] BROLIN RE, KENLER HA, GORMAN JH, et al.Long-limb gastric bypass in the superobese.A prospective randomized study[J].Ann Surg, 1992, 215(4):387. [8] SCHAUER PR, IKRAMUDDIN S, GOURASH W, et al.Outcomes after laparoscopic Roux-en-Y gastric bypass formorbid obesity[J].Ann Surg, 2000, 232(4):515.